| Study Period | 2019 - 2032 |
| 2024 Market Size | USD 10.9 Billion |
| 2025 Market Size | USD 12.1 Billion |
| 2032 Forecast | USD 26.7 Billion |
| Growth Rate (CAGR) | 12% |
| Largest Region | North America |
| Fastest Growing Region | APAC |
| Nature of the Market | Fragmented |
| Largest Application Category | Biomolecule Isolation |
|
Explore the market potential with our data-driven report
The global cell isolation market had the value of USD 10.9 billion in 2024, and the size is predicted to reach USD 26.7 billion by 2032, advancing at 12% CAGR during 2025–2032. It is driven by the rising demand for biopharmaceuticals, increasing government funding for cell-based research, and growing research on personalized medicine.
Cell isolation products are widely used by researchers in R&D facilities and research laboratories for various applications including biomolecule isolation, cancer research, stem cell research, and tissue regeneration. Thus, presence of large number of research institutes and biotechnology companies is the foremost factor promoting the growth of the industry.
Increase in investments and fundings by the government has led to an increase in the availability of technologically advanced processes for this technique and biopharmaceutical production. These advancements have resulted in an increased demand for cell separation procedures, thus boosting the market. The usage of cell-based therapies is on the rise for the treatment of neurological diseases including, amyotrophic lateral sclerosis, Parkinson's disease. In recent years, there has been an increase in the funding from government organizations for cell-based research owing to its ability to treat and manage cancer and chronic diseases.
The centrifugation technique accounted for the largest revenue share, of 40%, in 2024. It is the most often used technique in biological sciences for particle/microorganism separation via centrifuge. Particles are separated, based on their size, shape, density, medium viscosity, and rotor speed.
Centrifuging has several advantages, including enclosed operation and thus a clean appearance, fast start-up and shutdown, quick adjustment of operating variables, continuous operation, ready automation and thus suitability for unmanned operation, low capital cost-to-capacity ratio, and high installed capacity to building area ratio. The low cost of centrifugation for cell isolation is the main factor attributable for the largest share of centrifugation technique.
The surface marker category will witness the fastest growth during the forecast period. The biggest advantage of this technique over filtration and centrifugation is that it is not limited by the size or density of the cells. Additionally, surface markers are unique to each type of cells, which is why identifying the markers on the cell membrane makes it easy to identity the exact kind of cell. This way, this technique not only makes the diagnosis of diseases easier but also helps in personalized medicine. As a result, it is widely used in oncology to diagnose the kind and stage of cancer.
These techniques are covered:
The biomolecule isolation category is the largest, and it will grow the fastest during the forecast period, at a CAGR of 13%. This is because of an increasing interest of pharmaceutical companies in the development of drugs based on biomolecules due to their fewer side-effects compared to small molecules. Since biomolecules are essential in many biological activities, including disease development, reliable detection of biomolecules is vital for disease diagnosis and therapy. Also, the focus on biological compounds as medicine is increasing. It contributes to new developments in gene and cell therapies, immunotherapies, and antibody-drug conjugates.
These applications are covered:
Research laboratories & institutes dominate the market with 55% share in 2024. This is attributed to the growing research in oncology, precision medicine, biopharmaceuticals, biomarkers for different diseases, point-of-care diagnostics, cell & gene therapy, and tissue engineering & regeneration. Cell isolation techniques are also used in polymerase chain reaction (PCR), epigenetics, and electrophoresis in research institutes. Government bodies sponsor certain organizations to work in collaboration with research institutions, which is likely to be responsible for increasing penetration of cell isolation techniques in research laboratories and institutes.
The demand for cell isolation products in hospitals and diagnostic laboratories will observe the fastest growth during the forecast period. The increasing incidence of viral and bacterial infections has led to increasing demand for cell isolation products in hospitals and diagnostic laboratories for bacteria and virus isolation using cell culture.
These end users are covered:
Consumables hold the larger share, and they will also have the higher CAGR during the forecast period, of 14%. This is owing to the requirement of various reagents, kits, media, sera, beads, and disposables for carrying out the process of cell isolation. The key reason for their larger share is that are a repetitive purchase, being exhaustive in nature. On the other hand, instruments, although expensive, are a one-time purchase and need to be merely upgraded and repaired regularly.
These products are covered:
Animal cells dominate the market with 60% revenue on account of the wide usage of animals and animal cells in healthcare R&D. Before any medical device or drug is tested on humans, it is tested on animals. Hence, as the global healthcare R&D pipeline grows, the demand for equipment and consumables to separate and isolate animal cells will keep rising.
The human cells category will witness the faster growth during the forecast period. This is because of the rising number of drugs and medical devices under clinical trials to test their efficacy, mechanism of action, safety, interaction with other drugs, and potential side-effects. Moreover, with the increasing concerns over animal welfare, the usage of human cells in preclinical trials may surge rapidly. Additionally, the advent of the organ-on-chip approach could ensure that lab-grown human tissues can be used in clinical trials instead of an entire person.
These cell types are covered:
Drive strategic growth with comprehensive market analysis
North America was the largest market for cell isolation products, contributing around 40% in 2024. The largest share of the market is attributable to the presence of large number of research laboratories, academic institutes, pharmaceutical and biotechnology companies as well as hospitals and diagnostic laboratories, which carry out extensive research that utilizes cell isolation instruments and consumables.
The cell isolation product manufacturers are majorly focusing on development, commercialization, and distribution of advanced products to cater the needs of researchers and healthcare professionals.
Increasing focus on biomedical, stem cells, and cancer research is a key factor contributing toward its largest share. The increasing prevalence of chronic diseases such as cardiovascular diseases will fuel growth of the industry. Prevalence of cancer is increasing, thus, there is increasing focus on cancer and stem cell research. Stem cell therapy is the most promising technique to treat severe medical conditions, including cancer and blood diseases. Thus, biotechnology and biopharmaceutical companies are adopting advanced cell separation products, such as magnetic beads for the research and development of stem cells, which is projected to drive the market growth.
Also, in Canada there has been an increasing investment in research by the government and companies, which is projected to reinforce the market. In addition, the rising number of product approvals and presence of broad network of distribution channels of global players in Canada will boost the industry in the country.
Moreover, Europe was the second largest cell isolation market in 2022. It will showcase lucrative growth during the forecast period, owing to the presence of well-developed research infrastructure, availability of advanced products, and skilled professionals. Rising demand for progressive diagnostics and therapeutics products in Europe is another factor, which will support the growth of the industry. Furthermore, relatively less stringent product approval processes in this region are projected to boost the market growth.
In the U.K., there is an increasing focus on drug discovery and development and increasing government funding for new drug development. Cell isolation plays a vital role in the discovery and development of biologics. Thus, the demand for these products will rise in the near future. In addition, escalating demand for personalized medicine in the country will support the industry development. Personalized medicine is a medical therapy in which the treatment is customized for an individual based on the genetic or molecular analysis of the patient. Cell separation techniques can be used in personalized medicine for early detection of disease, selection of appropriate treatment, and determining the prognosis of the therapy.
Among all the regions, the APAC cell isolation market is projected to showcase highest growth during the forecast period, owing to high presence of clinical research organizations and biopharmaceutical companies in this region. Developing economies, presence of large biotechnology companies, and rising prevalence of chronic diseases are some of the other factors boosting market growth in the region.
In the region, Shanghai, Taiwan, South Korea, New Zealand, Melbourne, and Singapore are among the most-significant hubs for the biotechnology sector. The strong government support for this sector, rising public and private investments, and large influx of skilled scientists from around the world boosts biotechnology R&D in these geographies. There not only global pharmaceutical companies carrying out R&D in these countries and cities but also home-grown ones.
Moreover, the growth of the biopharmaceutical industry in India and China are a major factor contributing to market growth, as these countries have large populations. The Chinese biopharmaceutical industry is more inclined toward providing biosimilar versions like the ones available in Western countries, in Chinese markets, whereas biopharma industry in India is inclined toward the production and development of biosimilars and biogenerics for export purposes. Thus, increased efficacy, ability to treat a wide range of diseases, and the growth of the biopharmaceutical industry in the Asian countries are the major factors driving the demand for these biological structures.
The regions and countries analyzed for this report include:
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages